Tatva Chintan’s Initial Public Offering

IndusLaw advised the Book Running Lead Managers on the offering.

Tatva Chintan Pharma Limited executed an initial public offering.

Tatva Chintan Pharma Chem Limited manufactures chemical products. The Company produces and markets tetrabutylammonium bromide, iodide, hydrogen sulphate, chloride, fluoride trihydrate, nitrate, acetate, and triiodide products.

The Book Running Lead Managers were ICICI Securities Limited and JM Financial Limited.

The IndusLaw team was led by Partner Ravi Dubey (Picture), Mansi Jhaveri (Senior Associate), Anjali Menon, Geethanjali Jujjavarapu and Yajunshi Tyagi (Associates).

Involved fees earner: Ravi Dubey – IndusLaw; Mansi Jhaveri – IndusLaw; Geethanjali Jujjavarapu – IndusLaw; Anjali Menon – IndusLaw; Yajunshi Tyagi – IndusLaw;

Law Firms: IndusLaw;

Clients: ICICI Securities Ltd.; JM Financial;

Author: Sonia Carcano